NCT02500173

Brief Summary

To collect and analyze effects and side effects in patients undergoing radiotherapy. This study investigates how analysis of effects and side effects will influence outcome of patients. These retrospectively collected data allow to adapt and improve radiotherapy treatment regimens .

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

June 18, 2015

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 16, 2015

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2020

Completed
Last Updated

March 9, 2021

Status Verified

March 1, 2021

Enrollment Period

5.4 years

First QC Date

June 18, 2015

Last Update Submit

March 7, 2021

Conditions

Cancer

Keywords

radiotherapyside effects

Outcome Measures

Primary Outcomes (1)

  • Side effects in patients undergoing radiotherapy (CTCAE v4.03)

    acute and late side effects according to CTCAE

    5 Years

Interventions

RadiationRADIATION

Radiation therapy

Eligibility Criteria

Age20 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing radiotherapy at the Kantonsspital Graubuenden

You may qualify if:

  • Patients undergoing radiotherapy at the Kantonsspital Graubuenden

You may not qualify if:

  • No radiotherapy at Kantonsspital Graubuenden
  • Age: \< 20 years, \> 105 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kantonsspital Graubuenden, Department of Radiaton Oncology

Chur, 7000, Switzerland

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Radiation

Intervention Hierarchy (Ancestors)

Physical Phenomena

Study Officials

  • Daniel R Zwahlen, MD MBA

    Kantonsspital Winterthur, Department of Radiation Oncology

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2015

First Posted

July 16, 2015

Study Start

June 1, 2015

Primary Completion

October 21, 2020

Study Completion

October 21, 2020

Last Updated

March 9, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations

CH(1)